Exact Mass: 456.3051
Exact Mass Matches: 456.3051
Found 500 metabolites which its exact mass value is equals to given mass value 456.3051
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Citranaxanthin
Citranaxanthin is found in citrus. Citranaxanthin is a constituent of Sinton citrangequat (a Citrus-Poncirus-Fortunella hybrid) Citranaxanthin is a carotenoid pigment used as a food additive under the E number E161i as a food coloring. There are natural sources of citranaxanthin, but it is generally prepared synthetically. It is used as an animal feed additive to impart a yellow color to chicken fat and egg yolks. Constituent of Sinton citrangequat (a Citrus-Poncirus-Fortunella hybrid)
N-Docosahexaenoyl Glutamine
N-docosahexaenoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Glutamine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
N-Docosahexaenoyl Lysine
N-docosahexaenoyl lysine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Lysine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Lysine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Lysine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
13Z-Labdene-8alpha,15,16-triol 8-beta-L-xylopyranoside
12alpha-acetoxy-20,24beta-dimethylscalar-17-en-25,24-lactone|12alpha-acetoxy-20,24beta-dimethylscalar-17-eno-25,24-lactone
24,25-dihydro-27-desoxywithaferin A|27-desoxy-24,25-dihydrowithaferin A
(20R,22R)-3beta,20-dihydroxy-1-oxowitha-5,24-dienolide|3beta,20alphaF-dihydroxy-1-oxo-(22R)-witha-5,24-dienolide|3beta,20alphaF-dihydroxy-1-oxo-20R,22R-witha-5,24-dienolide
20alpha-dimethylamino-16beta-hydroxy-3-senecioylamino-5alpha-pregn-2-en-4-one|pachysamine N
3-Ketone-(3alpha,11alph)-3,11-Dihydroxy-24-nor-20(29)-lupen-28-oic acid
24xi-hydroperoxy-24-ethylcholesta-4,28(29)-dien-3,6-dione
12alpha-acetoxy-24-methyl-24-oxoscalar-16-en-22,25-dial
3-oxo-1beta-hydroxy-2-nor-1,3-cyclotirucalla-7,24-dien-21-oic acid|dysoxyhainic acid A
15-hydroxy-13-epi-manoyl oxide-14-O-alpha-L-arabinopyranoside|tarapacol-14-O-alpha-L-arabinopyranoside
(2beta,3beta)-2,3,23-Trihydroxy-28-nor-5,12-oleanadien-16-one|mimusopgenone
30-norhederagenin|3beta,23-dihydroxy-30-norolean-12,20(29)-dien-28-oic acid
2,3-Dihydro-(4beta,22R)-4,27-Dihydroxy-1-oxowitha-2,5,24-trienolide
3beta,6beta-dihydroxy-24-noroleana-12,4(23)-dien-27-oic acid
22-acetoxy-24-methyl-12,24-dioxoscalar-16-en-25-al
2-[12-(3,4-Methylenedioxyphenyl)dodecyl]-4-hydroxy-2,3,4,6,7,8-hexahydro-5H-1-benzopyran-5-one
2alpha,3alpha-dihydroxy-24-nor-4(23)-oleandien-28-oic acid|2alpha,3alpha-dihydroxy-24-nor-olean-4(23),12-dien-28-oic acid
24,25-Didehydro-(4beta,5beta,6beta,22R,24S,25R)-4-Hydroxy-5,6-epoxy-1-oxowithanolide
6alpha-hydroxy-17-phenylacetoxy-18-oxo-kolav-3-en-15-ol
2alpha,3beta-dihydroxy-30-noroleana-12,20(29)-dien-28-oic acid|2??,3??-Dihydroxy-30-noroleana-12,20(29)-dien-28-oic acid
12alpha-hydroxy-5,13-dioxoisohalidrol|12beta-hydroxy-513-dioxoisohalidrol
3beta,16beta-dihydroxy-30-norolean-12,20(29)-dien-28-oic acid|pfaffianol A|pfaffine A
3,20-dioxo-29-norlupan-28-oic acid|3,20-dioxo-30-norlupan-28-oic acid
(12beta,22R)-12-acetoxy-22-hydroxy-cholesta-1,4-dien-3-one
2alpha,3beta-dihydroxy-24-nor-urs-4(23),12-dien-28-oic acid|ilekudinol B
(12beta,22R)-12-hydroxy-22-acetoxy-cholesta-1,4-dien-3-one
(20R,22R)-20-hydroxy-22-acetoxy-cholesta-1,4-dien-3-one
3beta,21alpha-dihydroxy-27-oxo-30-nor-(D:A)-friedo-olean-20(29)-en-27,22alpha-lactone|glaucalactone
(+)-(3S,7S,8S,13R,14S,17R,18R,21S)-25-norfern-5(10),9(11)-diene-19-oxo-3,7,28-triol
28-Noroleana-16,21-diene-3alpha,19alpha,29-triol-23-al
(3E,11E)-6,19-epoxy-17,20-dihydroxycembra-3,6,8(19),11,15-pentaene 17,20-dibutanoate
(19alpha)-19-hydroxy-3-oxo-24-norolean-12-en-28-oic acid
(22E)-2-ethoxycarbonyl-2-beta-hydroxy-A-nor-cholest-5,22-diene-4-one|2-ethoxycarbonyl-2beta-hydroxy-A-nor-cholesta-5,22-dien-4-one
(20S,22R)-5alpha-spirost-25(27)-en-3beta-ol monoacetate
aglaiabbreviatin B
A tetracyclic triterpenoid isolated from the stems of Aglaia abbreviata.
12alpha-acetoxy-13beta,18beta-cyclobutane-20,24-dimethyl-24-oxoscalar-16-en-25alpha-ol|12alpha-acetoxy-13beta,18beta-cyclobutane-20,24-dimethyl-24-oxoscalar-16-en-25beta-ol
3-oxo-1alpha-hydroxy-2-nor-1,3-cycloolean-12-en-30-oic acid|dysoxyhainic acid B
Gly Lys Pro Arg
Gly Lys Arg Pro
Gly Pro Lys Arg
Gly Pro Arg Lys
Gly Arg Lys Pro
Gly Arg Pro Lys
Ile Ile Ile Val
Ile Ile Leu Val
Ile Ile Val Ile
Ile Ile Val Leu
Ile Leu Ile Val
Ile Leu Leu Val
Ile Leu Val Ile
Ile Leu Val Leu
Ile Val Ile Ile
Ile Val Ile Leu
Ile Val Leu Ile
Ile Val Leu Leu
Lys Gly Pro Arg
Lys Gly Arg Pro
Lys Asn Pro Val
Lys Asn Val Pro
Lys Pro Gly Arg
Lys Pro Asn Val
Lys Pro Arg Gly
Lys Pro Val Asn
Lys Arg Gly Pro
Lys Arg Pro Gly
Lys Val Asn Pro
Lys Val Pro Asn
Leu Ile Ile Val
Leu Ile Leu Val
Leu Ile Val Ile
Leu Ile Val Leu
Leu Leu Ile Val
Leu Leu Leu Val
Leu Leu Val Ile
Leu Leu Val Leu
Leu Val Ile Ile
Leu Val Ile Leu
Leu Val Leu Ile
Leu Val Leu Leu
Asn Lys Pro Val
Asn Lys Val Pro
Asn Pro Lys Val
Asn Pro Val Lys
Asn Val Lys Pro
Pro Gly Lys Arg
Pro Gly Arg Lys
Pro Lys Gly Arg
Pro Lys Arg Gly
Pro Arg Gly Lys
Pro Arg Lys Gly
Arg Gly Lys Pro
Arg Gly Pro Lys
Arg Lys Gly Pro
Arg Lys Pro Gly
Arg Pro Gly Lys
Arg Pro Lys Gly
Val Ile Ile Ile
Val Ile Ile Leu
Val Ile Leu Ile
Val Ile Leu Leu
Val Leu Ile Ile
Val Leu Ile Leu
Val Leu Leu Ile
Val Leu Leu Leu
(5Z,7E)-(1S,3R,22S)-26,27-dimethyl-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(5Z,7E)-(1S,3R,20R,22R)-24a,24b-dihomo-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(5Z,7E)-(1S,3R,20R,22S)-24a,24b-dihomo-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(5Z,7E)-(1S,3R,20R,22R)-26,27-dimethyl-9,10-seco-5,7,10(19)-cholestatrien-23-yne-1,3,22,25-tetrol
(5Z,7E)-(1S,3R)-18-(5-hydroxy-5-methyl-2-hexynyloxy)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol
(5Z,7E)-(1S,3R)-18-(5-hydroxy-5-methyl-3-hexynyloxy)-23,24-dinor-9,10-seco-5,7,10(19)-cholatriene-1,3-diol
24,24-Difluoro-1,25,26-trihydroxyvitamin D3
Citranaxanthin
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
(22R)-1alpha,22,25-trihydroxy-23,24-tetradehydro-24a,24b-dihomo-20-epivitamin D3
(22S)-1alpha,22,25-trihydroxy-23,24-tetradehydro-24a,24b-dihomo-20-epivitamin D3
(22R)-1alpha,22,25-trihydroxy-26,27-dimethyl-23,24-tetradehydro-20-epivitamin D3
1,3-Benzodioxole,5-[bis[2-(2-butoxyethoxy)ethoxy]methyl]-
1-(3-chloro-4-methylphenyl)-4-[6-[4-(2-methylbutan-2-yl)phenoxy]hexyl]piperazine
butyl 2-methylprop-2-enoate,butyl prop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid
1,3,5-Tris(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzene
Dequalinium
G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AC - Quinoline derivatives D - Dermatologicals > D08 - Antiseptics and disinfectants > D08A - Antiseptics and disinfectants > D08AH - Quinoline derivatives R - Respiratory system > R02 - Throat preparations > R02A - Throat preparations > R02AA - Antiseptics C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents
Tolypodiol
A diterpenoid natural product obtained from the cyanobacterium Tolypothrix nodosa. It shows strong anti-inflammatory activity in the mouse ear edema assay.
N-[(4-dimethylaminophenyl)methyl]-7-methoxy-N-(4-propan-2-ylphenyl)-1,2,3,4-tetrahydronaphthalene-1-carboxamide
Ethanaminium, N-[4-[bis[4-(diethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-
n4-Hydroxy-2-isobutyl-n1-(9-oxo-1,8-diaza-tricyclo[10.6.1.013,18]nonadeca-12(19),13,15,17-tetraen-10-yl)-succinamide
N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
2-[4-[[5-[(1,2,4a,5-Tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]butyl]guanidine
[(1S,2R,3S,4S,5R)-5-azaniumyl-2-[(2R,3R,6S)-3-azaniumyl-6-(azaniumylmethyl)oxan-2-yl]oxy-4-[(2S,3R,4S,5S,6R)-4-azaniumyl-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-hydroxycyclohexyl]azanium
[3-carboxy-2-[(Z)-17-carboxyheptadec-9-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-17-carboxyheptadec-9-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(E)-17-carboxyheptadec-11-enoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(10E,12E)-9-hydroperoxyoctadeca-10,12-dienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[(9E,11E)-13-hydroperoxyoctadeca-9,11-dienoyl]oxypropyl]-trimethylazanium
5-amino-2-[[(4E,7E,10E,13E,16E,19E)-docosa-4,7,10,13,16,19-hexaenoyl]amino]-5-oxopentanoic acid
(2E,6Z)-13-hydroxy-1-(2-hydroxy-5-methoxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,14-triene-5,12-dione
A meroterpenoid that is hexadeca-2,6,14-triene-5,12-dione substituted by a hydroxy group at position 13, a 2-hydroxy-5-methoxy-3-methylphenyl group at position 1 and methyl groups at positions 3, 7, 11 and 15. Isolated from Halidrys siliquosa, it exhibits antibacterial and antifouling activities.
(10Z,14E)-2,6,10,14-Tetramethyl-5-hydroxy-16-(2-hydroxy-3-methyl-5-methoxyphenyl)-2,10,14-hexadecatriene-4,12-dione
(10E,14E)-5-hydroxy-16-(2-hydroxy-5-methoxy-3-methylphenyl)-2,6,10,14-tetramethylhexadeca-2,10,14-triene-4,12-dione
(2E,6E)-13-Hydroxy-1-(2-hydroxy-5-methoxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,14-triene-5,12-dione
23-Deoxypaeonenoide A, (rel)-
A natural product found in Paeonia rockii subspeciesrockii.
(1R,9R,10S,12R,13S,14R,15R,16S,17S,18R)-15-[3-(diethylamino)-2-hydroxypropyl]-13-ethyl-8-methyl-8-aza-15-azoniahexacyclo[14.2.1.01,9.02,7.010,15.012,17]nonadeca-2,4,6-triene-14,18-diol
D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
3beta,23-Dihydroxy-30-nor-olean-12,20-dien-28-oic acid
A natural product found in Paeonia rockii subspeciesrockii.
(1R,9S,10S,11S)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-N-(3-morpholin-4-ylpropyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
1-[(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(4-morpholinyl)ethanone
(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-N-(3-morpholin-4-ylpropyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-(4-morpholinyl)ethanone
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-1-(4-oxanylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
1-[(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(4-morpholinyl)ethanone
N-[(2R,3R,4aS,6S,8aS)-2-[2-[4-(1-cyclohexenyl)phenyl]ethyl]-6-(hydroxymethyl)-2,3,4,4a,6,7,8,8a-octahydropyrano[3,2-b]pyran-3-yl]-2-(dimethylamino)acetamide
1-({(1s,4s,6s)-6-Isopropyl-3-methyl-4-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-2-cyclohexen-1-yl}methyl)-3-(3-methoxyphenyl)urea
2,3-Dihydroxypropyl (2-hydroxy-3-pentadecoxypropyl) hydrogen phosphate
[1-carboxy-3-[2-hydroxy-3-[(9E,12E)-pentadeca-9,12-dienoyl]oxypropoxy]propyl]-trimethylazanium
(25R)-12alpha-hydroxy-24R,26R-dimethyl-26,27-cyclo-cholest-4-en-3,6-dione
2-[4-(2-hydroxy-5-methoxy-3-methylphenyl)-2-methylbut-2-en-1-yl]-4-(2-hydroxypropan-2-yl)-6a,9a-dimethyl-4h,5h,7h,8h,9h-cyclopenta[d]oxocin-6-one
methyl (2e,6e,10s,11z)-12-(2,5-dihydroxy-4-methylphenyl)-10-hydroxy-6,10-dimethyl-2-(4-methylpent-3-en-1-yl)dodeca-2,6,11-trienoate
(2e,6z,13e)-15-hydroxy-1-(5-hydroxy-2-methoxy-3-methylphenyl)-3,7,11,15-tetramethylhexadeca-2,6,13-triene-5,12-dione
ethyl 2-[(1r,2r,5r,7s,8s,11s,12r)-11-(acetyloxy)-2,7,8-trihydroxy-2,8,12-trimethyl-15-oxabicyclo[10.2.1]pentadecan-5-yl]prop-2-enoate
(1r,5s,6s,9r,10r,13s,14r,16r)-13-[(2r)-2-hydroxy-6-methyl-4-oxohept-5-en-2-yl]-5,9,10-trimethyl-6-(prop-1-en-2-yl)-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadecan-3-one
(2e)-3-[(1e,3s,5e,9e,11z,14r,15z)-14-methoxy-3,15,18-trimethylnonadeca-1,5,9,11,15,17-hexaen-1-yl]pent-2-enedioic acid
(2s,3r,4s,5s)-2-{1-[(3s,4ar,6as,10as,10br)-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-hydroxyethoxy}oxane-3,4,5-triol
(1r,3as,3br,9ar,9bs,11as)-1-[(2r,5r)-5-ethyl-5-hydroxy-6-methylhept-6-en-2-yl]-9a-methyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-11a-carboxylic acid
(1r,3s,3ar,5ar,5br,7ar,9r,11br,13ar,13br)-3,9-dihydroxy-3a-(hydroxymethyl)-5a,5b,8,8-tetramethyl-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,9h,11bh,12h,13h,13ah,13bh-cyclopenta[a]chrysen-10-one
methyl (1s,2r,4s,9s,10s,13r,14r)-13-[(2r,3e)-5,6-dimethylhept-3-en-2-yl]-4-hydroxy-2,14-dimethyl-5-oxotetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadec-6-ene-4-carboxylate
(9ar,11ar)-1-[(2r)-5-hydroperoxy-5-isopropylhept-6-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione
(4as,6as,6br,9r,10r,11s,12ar,12bs,14br)-10,11-dihydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,4a,6,7,10,11,12,12b,13,14b-dodecahydropicen-5-one
(1s,5ar,7s,7as,11ar,11br,13as,13br)-7-(acetyloxy)-8,8,11a,13a-tetramethyl-1h,3h,5h,5ah,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-1-yl acetate
2-(1-{3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl}-2-hydroxyethoxy)oxane-3,4,5-triol
(4ar,5r,6as,6br,8as,9r,12as,14bs)-5-hydroxy-2,2,6a,6b,9,12a-hexamethyl-10-oxo-1,3,4,5,6,7,8,8a,9,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
10,11-dihydroxy-6a,6b,9,9,12a-pentamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(2r)-1-[(1s,4's,5s,6r,7s)-4'-hydroxy-1,5,5',5'-tetramethylspiro[bicyclo[3.2.0]heptane-6,2'-oxolan]-7-yl]-2-[(2-hydroxy-5-methoxy-3-methylphenyl)methyl]-3-methylbut-3-en-1-one
14-(dimethylamino)-5-(isoquinolin-7-yl)-6-methyl-19-oxapentacyclo[14.2.1.0¹,⁹.0²,⁶.0¹¹,¹⁶]nonadeca-9,11-dien-13-ol
(4as,6as,6br,8ar,9s,10r,12ar,12br,14bs)-10-hydroxy-9-(hydroxymethyl)-6a,6b,9,12a-tetramethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(4e)-1-[(1r,2r)-2-[(2e)-4-hydroxy-4-methylpent-2-enoyl]-1,2-dimethylcyclopentyl]-6-(2-hydroxy-5-methoxy-3-methylphenyl)-4-methylhex-4-en-2-one
(2r,3s,4r,5s)-2-{[(1r,2r,4as,8as)-1-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-2-yl]oxy}oxane-3,4,5-triol
methyl 4,14-dihydroxy-1,1,4a,6a,12b-pentamethyl-2h,3h,4h,4bh,5h,6h,12h,12ah,13h,14h,14ah-naphtho[2,1-a]xanthene-10-carboxylate
methyl (2z,6e,10s,11z)-12-(2,5-dihydroxy-4-methylphenyl)-10-hydroxy-6,10-dimethyl-2-(4-methylpent-3-en-1-yl)dodeca-2,6,11-trienoate
2-({1-[5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-2-yl}oxy)oxane-3,4,5-triol
(10z,14e)-5-hydroxy-16-(2-hydroxy-5-methoxy-3-methylphenyl)-2,6,10,14-tetramethylhexadeca-2,10,14-triene-4,12-dione
6-hydroxy-12-methyl-2,5-dioxo-1-oxacyclododecan-3-yl 4,11-dihydroxydodec-2-enoate
2,3-dimethoxy-5-methyl-6-[(2e,6e,10e)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]benzene-1,4-diol
(2r,2ar,5as,5br,7as,8s,11as,11br,13s,13as)-3-acetyl-8-ethyl-2-hydroxy-5b,8,11a-trimethyl-1h,2h,2ah,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-cyclobuta[i]chrysen-13-yl acetate
12-hydroxy-5a,5b,8,11a-tetramethyl-9-oxo-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
(1s,2r,7s,9r,11s,12s,15r,16s)-15-[(1s)-1-[(2r)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-2,16-dimethyl-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecan-3-one
(1s,3r)-3-[(3e,7e)-9-(4-hydroxy-6-methyl-2-oxopyran-3-yl)-3,7-dimethylnona-3,7-dien-1-yl]-2,2-dimethyl-4-methylidenecyclohexyl acetate
(1r,4ar,7ar)-3-[(2e)-4-(2-hydroxy-5-methoxy-3-methylphenyl)-2-methylbut-2-en-1-yl]-4a,5',5',7a-tetramethyl-6,7-dihydro-5h-spiro[cyclopenta[c]pyran-1,2'-oxolan]-4'-ol
(3e,5e,7e,9s,11e,13r,14r,15s,16r,17z,19e,22s)-22-[(1e)-but-1-en-1-yl]-14,15,16-trihydroxy-5,9,13-trimethyl-1-oxacyclodocosa-3,5,7,11,17,19-hexaen-2-one
methyl (10s)-12-(2,5-dihydroxy-4-methylphenyl)-10-hydroxy-6,10-dimethyl-2-(4-methylpent-3-en-1-yl)dodeca-2,6,11-trienoate
(2s)-3-[(1r,5s)-5-hydroxy-4-[(3e)-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-3-en-1-yl]cyclohex-3-en-1-yl]-5-oxo-2h-furan-2-yl acetate
9,18-dihydroxy-2,16-dimethyl-15-{1-[2-(3-methylbutan-2-yl)cyclopropyl]ethyl}-7-oxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹²,¹⁶]octadec-4-en-3-one
2,3-dihydroxy-24-nor-4(23),12-oleanadien-28-oic acid; (2α,3β)-form
{"Ingredient_id": "HBIN004041","Ingredient_name": "2,3-dihydroxy-24-nor-4(23),12-oleanadien-28-oic acid; (2\u03b1,3\u03b2)-form","Alias": "NA","Ingredient_formula": "C29H44O4","Ingredient_Smile": "NA","Ingredient_weight": "456.66","OB_score": "NA","CAS_id": "189116-23-2","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8939","PubChem_id": "NA","DrugBank_id": "NA"}
2α,3α-dihydroxy-30-noroleana-12,20(29)-dien-28-oicacid
{"Ingredient_id": "HBIN005183","Ingredient_name": "2\u03b1,3\u03b1-dihydroxy-30-noroleana-12,20(29)-dien-28-oicacid","Alias": "NA","Ingredient_formula": "C29H44O4","Ingredient_Smile": "CC1(C2CCC3(C(C2(CC(C1O)O)C)CC=C4C3(CCC5(C4CC(=C)CC5)C(=O)O)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6049","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2α,3β-dihydroxy-30-noroleana-12,20(29)-dien-28-oicacid
{"Ingredient_id": "HBIN005225","Ingredient_name": "2\u03b1,3\u03b2-dihydroxy-30-noroleana-12,20(29)-dien-28-oicacid","Alias": "NA","Ingredient_formula": "C29H44O4","Ingredient_Smile": "CC1(C2CCC3(C(C2(CC(C1O)O)C)CC=C4C3(CCC5(C4CC(=C)CC5)C(=O)O)C)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6050","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}